REGENERON PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 965.6 USD | +1.03% |
|
+2.71% | +9.65% |
Chart calendar Regeneron Pharmaceuticals, Inc.
41af41b15ff.apPqOBmWPGk_8_SLBQ2N15UHFILPTBe6iJf5J5NgBjY.GKunAWm7TThRwsLIa1W7vvFOVcucPDri-824U_Y2Y0UC0ccLRtELG1vDnw~5b309ed9eb32557487abbf22809f63ac
Upcoming events on Regeneron Pharmaceuticals, Inc.
Past events on Regeneron Pharmaceuticals, Inc.
| Today 06:45 pm | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #4887 |
| Today 06:15 pm | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #4906 |
| 2024-05-08 05:15 pm | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #4928 |
| 2024-05-08 04:15 pm | American Society of Gene & Cell Therapy Meeting - Abstract No - 118 |
| 2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No - 898 |
| 2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No -897 |
| 2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No - 899 |
| 2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No -638 |
| 2024-05-08 09:30 am | American Society of Gene & Cell Therapy Meeting - Abstract No - 10 |
| 2024-05-07 11:30 am | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #A0441 |
| 2024-05-06 06:30 pm | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #2115 |
| 2024-05-06 03:45 pm | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #2116 |
| 2024-05-05 04:00 pm | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #B0369 |
| 2024-05-05 11:00 am | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #B0283 |
| 2024-05-05 11:00 am | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #B0282 |
| 2024-05-05 11:00 am | Association for Research in Vision and Ophthalmology Meeting - Abstract No. #B0280 |
| 2024-05-02 08:30 am | Q1 2024 Earnings Call |
| 2024-05-02 06:30 am | Q1 2024 Earnings Release |
| 2024-03-13 10:40 am | Leerink Partners Global Biopharma Conference |
| 2024-03-12 11:15 am | Barclays Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7 863 7 816 0.61% | 8 497 8 494 0.04% | 16 072 15 679 2.51% | 12 173 11 850 2.73% | 13 117 12 921 1.52% | 13 847 |
|
EBITDA Million USD | Released Forecast Spread | 3 420 3 610 -5.28% | 4 245 4 158 2.09% | 9 835 9 709 1.29% | 6 060 6 161 -1.63% | 5 547 5 452 1.74% | 5 528 |
|
EBIT Million USD | Released Forecast Spread | 2 210 2 285 -3.29% | 3 577 3 485 2.64% | 8 947 9 034 -0.96% | 5 719 5 561 2.84% | 5 126 5 082 0.87% | 5 087 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 429 2 308 5.26% | 3 810 3 582 6.39% | 9 326 9 442 -1.23% | 4 859 4 812 0.97% | 4 199 4 276 -1.8% | 4 225 |
|
Net income Million USD | Released Forecast Spread | 2 116 1 998 5.87% | 3 513 3 160 11.18% | 8 075 8 014 0.77% | 4 338 4 166 4.14% | 3 954 3 808 3.83% | 4 055 |
|
EPS USD | Released Forecast Spread | 18,5 17,6 4.67% | 30,5 28,0 8.96% | 72,0 71,1 1.17% | 38,2 36,3 5.31% | 34,8 33,9 2.62% | 35,2 |
| Announcement Date | 06/02/20 | 05/02/21 | 04/02/22 | 03/02/23 | 02/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 965 2 690 10.22% | 2 857 2 797 2.14% | 2 936 2 870 2.29% | 3 414 3 113 9.7% | 3 162 2 998 5.48% | 3 158 3 025 4.41% | 3 363 3 222 4.36% | 3 434 3 287 4.49% | 3 145 3 221 -2.35% | 3 386 | 3 561 | 3 726 | 3 594 | 3 664 |
|
EBITDA Million USD | Released Forecast Spread | 1 558 1 376 13.24% | 1 344 1 220 10.17% | 1 488 1 344 10.67% | 1 637 1 336 22.54% | 1 315 1 219 7.84% | 1 351 1 175 14.98% | 1 488 1 288 15.47% | 1 395 1 500 -7.01% | 1 142 1 195 -4.43% | 1 311 | 1 495 | 1 613 | 1 193 | 1 285 |
|
EBIT Million USD | Released Forecast Spread | 1 483 1 273 16.56% | 1 285 1 124 14.37% | 1 413 1 266 11.62% | 1 537 1 344 14.33% | 1 215 1 203 1.01% | 1 248 1 216 2.63% | 1 382 1 272 8.7% | 1 282 1 248 2.74% | 1 028 1 168 -12.04% | 1 214 | 1 346 | 1 411 | 1 311 | 1 369 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 061 1 185 -10.43% | 963 1 116 -13.71% | 1 510 984 53.36% | 1 325 1 154 14.81% | 858 1 009 -14.97% | 1 083 1 041 4% | 1 111 1 154 -3.72% | 1 148 1 308 -12.24% | 701 1 212 -42.18% | 1 111 | 1 171 | 1 196 | 1 233 | 1 339 |
|
Net income Million USD | Released Forecast Spread | 974 1 038 -6.2% | 852 794 7.38% | 1 316 845 55.67% | 1 197 1 060 12.94% | 818 876 -6.69% | 968 885 9.42% | 1 008 1 071 -5.9% | 1 160 1 025 13.08% | 722 886 -18.54% | 1 043 | 1 145 | 1 169 | 1 109 | 1 155 |
|
EPS USD | Released Forecast Spread | 8,61 8,77 -1.86% | 7,47 7,38 1.29% | 11,7 7,93 47.05% | 10,5 9,23 13.73% | 7,17 7,96 -9.92% | 8,50 7,93 7.12% | 8,89 9,04 -1.62% | 10,2 9,21 10.69% | 6,27 7,89 -20.52% | 8,87 | 9,64 | 9,99 | 9,80 | 10,2 |
| Announcement Date | 04/05/22 | 03/08/22 | 03/11/22 | 03/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 02/02/24 | 02/05/24 | - | - | - | - | - |
More events
Past sector events for Regeneron Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- REGN Stock
- Calendar Regeneron Pharmaceuticals, Inc.